Pharmacogenomics
HeartGenetics' Pharmacogenomics DNA tests provide healthcare professionals with more efficient ways to plan the best-suited medication strategies for their patients. MyPharmaGenes® PGx is a comprehensive test for the definition of a personalized pharmacological plan for the treatment of pathologies across different therapeutic areas. Warfarin PGx, Simvastatin PGx and Clopidogrel PGx provide insights into how the patient responds to these compounds.
MyPharmaGenes® PGx
Comprehensive Pharmacogenetic study
![](https://www.heartgenetics.com/files/uploads/2022/05/heartgenetics-mypharmagenes-main-1024x823.jpg)
MyPharmaGenes® Brain PGx
Pharmacogenetic study
![](https://www.heartgenetics.com/files/uploads/2023/02/pexels-pixabay-51929-1024x678.jpg)
DPYD PGx
DNA Test of Fluoropyrimidines metabolism
![](https://www.heartgenetics.com/files/uploads/2022/07/dpyd_pgx-1-1024x572.webp)
MyCannabisGenes® PGx
DNA test to guide individual cannabinoid therapy
![](https://www.heartgenetics.com/files/uploads/2022/07/cannabis_genes-1-1024x572.webp)
Warfarin PGx
DNA test to assess warfarin metabolism
![](https://www.heartgenetics.com/files/uploads/2022/05/heartgenetics-warfarin-main-1024x823.jpg)
Simvastatin PGx
DNA test to assess simvastatin metabolism
![](https://www.heartgenetics.com/files/uploads/2022/05/heartgenetics-simvastatin-main-1024x823.jpg)
Clopidogrel PGx
DNA test to assess clopidogrel metabolism
![](https://www.heartgenetics.com/files/uploads/2022/05/heartgenetics-clopidogrel-main-1024x823.jpg)